CRISPR in der biotechnologischen Forschung und Entwicklung
- First Online:
- Cite this article as:
- Pul, Ü., Mampel, J., Zurek, C. et al. Biospektrum (2016) 22: 62. doi:10.1007/s12268-016-0659-2
- 94 Downloads
The discovery of programmable double-stranded DNA specific nucleases derived from the prokaryotic immunity systems CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) has opened a new era of genome editing and its applications in industrial biotechnology. Simple reprogramming of the DNA-specificity of CRISPR nucleases by RNAs allows the engineering of novel eukaryotic screening or producer cells through gene knock-out, chromosomal deletion and the regulation of gene expression.